Altered phosphate metabolism in HIV-1-infected patients with metabolic syndrome

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 2, 2012, Pages 133-137

  Grima, Pierfrancesco ^a   Guido, Marcello ^b   Chiavaroli, Roberto ^a   Stano, Francesca ^a   Tundo, Paolo ^a   Tana, Mariangela ^a   De Donno, Antonella ^b   Zizza, Antonella ^c  

^a S Caterina Novella Hospital   (Italy)

^b UNIVERSITY OF SALENTO   (Italy)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

HIV; Metabolic syndrome; Phosphate

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PHOSPHATE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INSULIN BLOOD LEVEL; KIDNEY TUBULE FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PHOSPHATES; YOUNG ADULT;

EID: 84856084177     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2011.623312     Document Type: Article

References (27)

1. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodefi ciency virus infection. HIV outpatient Study investigators. N Engl J Med 1998;338:853-60. (Pubitemid 28135961)
2. Behrens G, Dejam A, Schmidt H, Balks HJ, Brabant G, K ö rner T, et al. Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors. AIDS 1999;13:F63 - 70. (Pubitemid 29361082)
3. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:F51 - 8. (Pubitemid 28190689)
4. Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet 2000;356:1423-30.
5. Martinez E, Milinkovic A, Buira E, de Lazzari E, Leó n A, Larrousse M, et al. Incidence and causes of death in HIVinfected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area. HIV Med 2007;8: 251-8. (Pubitemid 46695372)
6. Lewden C, May T, Rosenthal E, Burty C, Bonnet F, Costagliola D, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: the Mortalité 2000 and 2005 surveys (ANRS EN19 and Mortavic).J Acquir Immune Defi c Syndr 2008;48:590-8.
7. Isomaa B, Almgren P, Tuomi T, Forsé n B, Lahti K, Nissé n M, et al. Cardiovascular morbidity and mortality associated with metabolic syndrome. Diabetes Care 2001;24: 683-9. (Pubitemid 32893993)
8. Jerico C, Knobel H, Montero M, Ordoñ ez-Llanos J, Guelar A, Gimeno JL, et al. Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors. Diabetes Care 2005;28:132-7. (Pubitemid 40095795)
9. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lefant C. Defi nition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientifi c issues related to defi nition. Arterioscler Thromb Vasc Biol 2004;24:13-8.
10. Haglin L. Hypophosphatemia: cause of the disturbed metabolism in the metabolic syndrome. Med Hypotheses 2001;56: 657-63. (Pubitemid 32588215)
11. Kalaitzidis R, Tsimihodimos V, Bairaktari E, Siamopoulos KC, Elisaf M. Disturbances of phosphate metabolism: another feature of metabolic syndrome. Am J Kidney Dis 2005;45:851-8. (Pubitemid 43181044)
12. Paula FJ, Plens AE, Foss MC. Effects of hypophosphatemia on glucose tolerance and insulin secretion. Horm Metab Res 1998;30:281-4. (Pubitemid 28267203)
13. Walton RJ, Bijvoet OL. Normogram for derivation of renal threshold phosphate concentration. Lancet 1975;2:309-10.
14. Walton RJ, Bijvoet OL. A simple slide-rule method for the assessment of renal tubular reabsorption of phosphate in man. Clin Chim Acta 1977;81:273-6. (Pubitemid 8221827)
15. Worm SA, Friis-M øl ler N, Bruyand M, D 'A rminio Monforte A, Rickenbach M, Reiss P, et al. High prevalence of the metabolic syndrome in HIV-infected patients: impact of different defi nitions of the metabolic syndrome. AIDS 2010;24: 427-35.
16. Bagnis CI, Karie S, Deray G, Essig M. Hypophosphataemia: an easy strategy for diagnosis and treatment in HIV patients. Antivir Ther 2009;14:481-8.
17. Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS 2004;18:541-6. (Pubitemid 38365883)
18. Karras A, Lafaurie M, Furco A, Bourgarit A, Droz D, Sereni D, et al. Tenofovir-related nephrotoxicity in human immunodefi ciency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus. Clin Infect Dis 2003;36:1070-3. (Pubitemid 36513295)
19. Creput C, Gonzales-Canali G, Hill G, Piketty C, Kazatchkine M, Nochy D. Renal lesions in HIV-1-positive patient treated with tenofovir. AIDS 2003;17:2543-4.
20. Cooper RD, Wiebe N, Smith N, Keiser P, Naicker S, Tonelli M. Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV infected patients. Clin Infect Dis 2010;51:496-505.
21. Mallon PW. HIV and bone mineral density. Curr Opin Infect Dis 2010;23:1-8.
22. Riley MS, Schade DS, Eaton RP. Effects of insulin infusion on plasma phosphate in diabetic patients. Metabolism 1979;28:191-4.
23. Bohannon NJ. Large phosphate shift with treatment for hyperglycemia. Arch Intern Med 1989;149:1423-5. (Pubitemid 19163543)
24. Ritz E, Kreusser W, Bommer J. Effects of hormones other than parathyroid hormone on renal handling of phosphate. In: Massry SG, Fleisch H, editors. Renal handling of phosphate. Plenum Medical Book Co; 1980 pp 137 - 95.
25. W eisinger JR, Bellorin-Font E. Magnesium and phosphorus. Lancet 1998;352:391.
26. Marshall WP, Banasiak MF, Kalkhoff RK. Effects of phosphate deprivation on carbohydrate metabolism. Horm Metab Res 1978;10:369-73. (Pubitemid 9044553)
27. Davis JL, Lewis SB, Schultz TA, Kaplan RA, Wallin JD. Acute and chronic phosphate depletion as a modulator of glucose uptake in rat skeletal muscle. Life Sci 1979;24:629-32 (Pubitemid 9132424)